1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow CORT113176: new trials by email Literature Review of CORT113176 trials Research Report on CORT113176
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dazucorilant in Patients With Amyotrophic Lateral Sclerosis Dazucorilant 300 mg, Dazucorilant 150 mg, Placebo - Amyotrophic Lateral Sclerosis | Phase 2 | Active not recruiting | Corcept Therapeutics | 279 | 2022-11-15 | 2026-09-24 |
Amyotrophic Lateral Sclerosis (1)
Belgium (1) · Canada (1) · France (1) · Germany (1) · Ireland (1) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)